Cargando…

Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever (VHF) endemic to China, South Korea, Japan, and Vietnam. Here we characterize the pathogenesis and natural history of disease in IFNAR(-/-) mice challenged with the HB29 strain of SFTS virus (SFTSV) and demonst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westover, Jonna B., Hickerson, Brady T., Van Wettere, Arnaud J., Hurst, Brett L., Kurz, Jacqueline P., Dagley, Ashley, Wülfroth, Petra, Komeno, Takashi, Furuta, Yousuke, Steiner, Thomas, Gowen, Brian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963364/ https://www.ncbi.nlm.nih.gov/pubmed/31546590 http://dx.doi.org/10.3390/pathogens8040158

Ejemplares similares

Pathogenesis of Rift Valley Fever Virus Aerosol Infection in STAT2 Knockout Hamsters
por: Hickerson, Brady T., et al.
Publicado: (2018)

Rift Valley Fever Virus Infection in Golden Syrian Hamsters
por: Scharton, Dionna, et al.
Publicado: (2015)

Vascular leak ensues a vigorous proinflammatory cytokine response to Tacaribe arenavirus infection in AG129 mice
por: Sefing, Eric J, et al.
Publicado: (2013)

Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters
por: Westover, Jonna B., et al.
Publicado: (2018)

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
por: Safronetz, David, et al.
Publicado: (2015)

Type I interferon underlies severe disease associated with Junín virus infection in mice
por: Hickerson, Brady T, et al.
Publicado: (2020)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening
por: Yamada, Hiroshi, et al.
Publicado: (2021)

Continuous hemodiafiltration for hypercytokinemia in tumor lysis syndrome
por: Nakamura, M, et al.
Publicado: (2005)

Hypercytokinemia and Pathogen–Host Interaction in COVID-19
por: Badawi, Alaa
Publicado: (2020)

Drug fever and acute inflammation from hypercytokinemia triggered by dipeptidyl peptidase‐4 inhibitor vildagliptin
por: Anno, Takatoshi, et al.
Publicado: (2018)

Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration
por: Tani, Hideki, et al.
Publicado: (2018)

Current and future developments in the treatment of virus-induced hypercytokinemia
por: Wong, Jonathan P, et al.
Publicado: (2017)

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
por: FURUTA, Yousuke, et al.
Publicado: (2017)

Cleavage‐Responsive Biofactory T Cells Suppress Infectious Diseases‐Associated Hypercytokinemia
por: Kim, Hyelim, et al.
Publicado: (2022)

Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients
por: Burgos-Blasco, Barbara, et al.
Publicado: (2020)

Interferon signaling and hypercytokinemia-related gene expression in the blood of antidepressant non-responders
por: Yamagata, Hirotaka, et al.
Publicado: (2023)

Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics
por: Zhong, Huahua, et al.
Publicado: (2023)

COVID-19 Severity Correlates with Weaker T-Cell Immunity, Hypercytokinemia, and Lung Epithelium Injury
por: Wang, Zhongfang, et al.
Publicado: (2020)

The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19
por: Guo, Jing, et al.
Publicado: (2020)

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
por: Mendenhall, Michelle, et al.
Publicado: (2011)

MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters
por: Gowen, Brian B., et al.
Publicado: (2015)

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
por: Bermejo-Martin, Jesus F, et al.
Publicado: (2009)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
por: Yamada, Kentaro, et al.
Publicado: (2016)

John Leake and Childbed Fever
por: Jameson, Edwin M.
Publicado: (1937)

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004)

Cleavage‐Responsive Biofactory T Cells Suppress Infectious Diseases‐Associated Hypercytokinemia (Adv. Sci. 26/2022)
por: Kim, Hyelim, et al.
Publicado: (2022)

Attenuated Response of Aged Mice to Respiratory Francisella novicida Is Characterized by Reduced Cell Death and Absence of Subsequent Hypercytokinemia
por: Mares, Chris A., et al.
Publicado: (2010)

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
por: de Jong, Menno D, et al.
Publicado: (2006)

Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection
por: Latha, Krishna, et al.
Publicado: (2021)

Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
por: Chapman, Nathaniel S., et al.
Publicado: (2023)

Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis
por: Ranadheera, Charlene, et al.
Publicado: (2020)

The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
por: Guo, Jing, et al.
Publicado: (2015)

Severe Fever with Thrombocytopenia Syndrome
por: Taniguchi, Tomohiro, et al.
Publicado: (2016)

Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
por: Gowen, Brian B., et al.
Publicado: (2008)

Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
por: Guo, Jing, et al.
Publicado: (2016)

Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2022)

Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease
por: Watts, Douglas M., et al.
Publicado: (2022)

Correlation between thrombocytopenia and host response in severe fever with thrombocytopenia syndrome
por: Li, Xiao-Kun, et al.
Publicado: (2020)

Interleukin-11-induced capillary leak syndrome in primary hepatic carcinoma patients with thrombocytopenia
por: Kai-Feng, Wang, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mdhhaesb0lkgdrf3us1q2jcpms